MRK Merck & Co., Inc.
Healthcare
Price
$130.18
Intrinsic value
$41.77
Buy price
$33.41
Discount
-211.7%
DCF walkthrough
Near-term growth (g1)3.12%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $19,967,000,000.00
- Total debt
- $53,910,999,040.00
- Cash & STI
- $7,141,000,192.00
- Shares out.
- 2,470,000,000
Overvalued [LOW CF reliability]
Intrinsic value$41.77
Buy price (with MOS)$33.41
Current price$130.18
Discount to intrinsic value-211.7%
7-step quality scorecard
ROE quality
HIGH_VOLATILE- Average ROE
- 26.0%
- Current ROE
- 34.7%
- Minimum ROE
- 1.0%
Debt quality
LEVERAGED- Debt / Equity
- 1.02x
Moat proxy
MODERATE_PROXYCash-flow reliability
LOW- Operating CF / Net income
- 6.29x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- revenueCAGR
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 35.9%
- Public economic interest
- 99.9%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.